Stay updated on PDR001 Plus LAG525 in Solid and Hematologic Malignancies Clinical Trial
Sign up to get notified when there's something new on the PDR001 Plus LAG525 in Solid and Hematologic Malignancies Clinical Trial page.

Latest updates to the PDR001 Plus LAG525 in Solid and Hematologic Malignancies Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedA new revision entry (v3.7.0) has been added to the history, signaling an update to the study page; the older revision (v3.6.6) is removed from the current history view.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedThe record history now shows a new revision entry, updating the page from v3.6.5 to v3.6.6. This reflects a minor platform update to the ClinicalTrials.gov interface rather than changes to study data.SummaryDifference0.1%

- Check54 days agoChange DetectedThe record history now shows a new revision entry 'Revision: v3.6.5' and drops the previous 'Revision: v3.6.4', updating the page's revision timeline. This reflects an administrative update to the page's version history rather than changes to study data.SummaryDifference0.1%

- Check68 days agoChange DetectedA new study record revision (v3.6.4) was added to the history, and the previous revision (v3.6.3) was removed from the list. This reflects an update to the record's version history.SummaryDifference0.1%

- Check90 days agoChange DetectedRevision label in the page footer updated from v3.6.2 to v3.6.3. This reflects a minor platform update to the record history page and does not change the trial data or visible content.SummaryDifference0.1%

- Check97 days agoChange DetectedThe page’s revision label changed from v3.6.0 to v3.6.2, indicating a minor version update on the study history page.SummaryDifference0.1%

Stay in the know with updates to PDR001 Plus LAG525 in Solid and Hematologic Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PDR001 Plus LAG525 in Solid and Hematologic Malignancies Clinical Trial page.